A kind of tyrosine kinase inhibitor, used for the treatment of chronic, accelerated, or acute myeloid leukemia (Ph+CML) in Philadelphia chromosome positive patients and adult patients with malignant gastrointestinal stromal tumors (GIST) that cannot be resected and/or metastasized.
The main content of this product is doxorubicin hydrochloride and the chemical name is 4-[(4-methyl-1-piperazine)methyl]-N-(4-methyl-3-[(4-(3-pyridine)-2-pyrimidine]amino]phenyl]-aniline mesilate.The chemical structure formula is as follows:C29H31N70·CH4S03 and the molecular weight is 589.70.
Suitable for chronic, accelerated, or acute myeloid leukemia (Ph+CML) in Philadelphia chromosome positive patients; Used to treat adult patients with malignant gastrointestinal stromal tumors (GIST) that cannot be resected and/or metastasized.
Oral administration.
1.Patients with allergic to the active substance or any excipient.
2.Pregnant women and lactating women.